Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 4F2 | P08195 | Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98) | Cancer-related genesCD markersEssential proteins | 1 | Acute myeloid leukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.40 | ||
| ANPRA | P16066 | Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) | 1 | AsthmaGeneral pain disorderHeart disease | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.40 | |||
| AT12A | P54707 | Potassium-transporting ATPase alpha chain 2 (HK alpha 2) (Non-gastric H(+)/K(+) ATPase subunit alpha) (EC 7.2.2.19) (Non-gastric Na(+)/K(+) ATPase subunit alpha) (EC 7.2.2.13) (Proton pump) (Sodium pump) | EnzymesMetabolic proteinsPlasma proteins | 10 | Fusion and delivery mediation | 2 | 0.40 | |||
| AT135 | Q4VNC0 | Probable cation-transporting ATPase 13A5 (EC 7.2.2.-) (P5-ATPase isoform 5) | Predicted membrane proteins | 10 | Fusion and delivery mediationMetabolism mediation | 2 | 0.40 | |||
| AT2B4 | P23634 | Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4) | EnzymesFDA approved drug targetsMetabolic proteins | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.40 | |||
| AT8B2 | P98198 | Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2) | EnzymesMetabolic proteinsPredicted membrane proteins | 10 | Fusion and delivery mediation | 2 | 0.40 | |||
| ATP4B | P51164 | Potassium-transporting ATPase subunit beta (Gastric H(+)/K(+) ATPase subunit beta) (Proton pump beta chain) | FDA approved drug targetsMetabolic proteinsPredicted membrane proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.40 | |||
| AVR2A | P27037 | Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA) | Cancer-related genesEnzymesPredicted membrane proteins | 1 | Acute myeloid leukaemiaIdiopathic inflammatory myopathyMuscle disorder | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 2 | 0.40 | ||
| C2C2L | O14523 | Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like) (C2CD2-like) (Transmembrane protein 24) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediationMetabolism mediation | 2 | 0.40 | |||
| EAA4 | P48664 | Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 8 | Fusion and delivery mediation | 2 | 0.40 |